Abstract | OBJECTIVE: PATIENTS AND METHODS: In all, 73 bladder tumours and 14 samples of normal bladder urothelium were studied by reverse-transcription polymerase chain reaction (PCR), real-time quantitative PCR and immunohistochemistry. RESULTS: The normalized CDC91L1 mRNA copy number in tumours was significantly greater than in normal controls (P < 0.05). There was overexpression of CDC91L1 mRNA in 30.1% (22/73) of the bladder tumours compared with the normal urothelium. At the protein level, 75.3% (55/73) of the bladder tumours and two of 14 of the normal urothelium had high expression of CDC91L1 protein, which is statistically significant (P < 0.001). The correlation between CDC91L1 protein and tumour grade, and muscle invasion of tumour was significant (both P < 0.05). In addition to tumour extent and tumour grade, CDC91L1 protein was an independent predictor of recurrence for superficial bladder cancer and had a trend to predict tumour progression. CONCLUSIONS: CDC91L1 (PIG-U) plays a role in the development of bladder urothelial cell carcinoma. CDC91L1 protein might be a potential biomarker for prediction of recurrence and a therapeutic target in bladder cancer.
|
Authors | Yi-Jun Shen, Ding-Wei Ye, Xu-Dong Yao, Barry Trink, Xiao-Yan Zhou, Shi-Lin Zhang, Bo Dai, Hai-Liang Zhang, Yao Zhu, Zhongmin Guo, Guojun Wu, Jatin Nagpal |
Journal | BJU international
(BJU Int)
Vol. 101
Issue 1
Pg. 113-9
(Jan 2008)
ISSN: 1464-410X [Electronic] England |
PMID | 17941920
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers, Tumor
- Acyltransferases
- COOH-terminal signal transamidase
|
Topics |
- Acyltransferases
(metabolism)
- Biomarkers, Tumor
(metabolism)
- Case-Control Studies
- Disease Progression
- Female
- Humans
- Immunohistochemistry
- Male
- Middle Aged
- Multivariate Analysis
- Neoplasm Recurrence, Local
(prevention & control)
- Neoplasm Staging
- Prognosis
- Reverse Transcriptase Polymerase Chain Reaction
- Urinary Bladder Neoplasms
(pathology)
- Urothelium
(pathology)
|